Multiple Sclerosis

Don't Miss

High-Fat Diets Could Pose Danger to Young MS Patients

These regimens raised the risk for disease relapse, study found
Resistance Training May Slow MS, Study Says

Scans revealed less brain shrinkage in exercise group
MS-Related Brain Changes May Affect Social Skills

Study might explain why some multiple sclerosis patients stop understanding what others are feeling

More Multiple Sclerosis News

Stem Cell Transplants May Help Some With Multiple Sclerosis
Review found younger patients fared better over 5 years, though some deaths reported
- Posted February 20, 2017
- 15
U.S. Report Cites the Good and Bad on Marijuana
Pot shown to help chronic pain, chemo-related nausea and muscle spasms in multiple sclerosis,...
- Posted January 12, 2017
- 17
New MS Drug Shows ‘Breakthrough’ Promise for Advanced Disease
Specialist hopes ocrelizumab will be available by spring
- Posted December 22, 2016
- 3
Could Low Vitamin D Levels at Birth Mean Higher MS Risk?
Perhaps, but researchers aren't ready to recommend routine supplementation during pregnancy
- Posted December 1, 2016
- 4
Could Low Vitamin D Levels at Birth Mean Higher MS Risk?
Perhaps, but researchers aren't ready to recommend routine supplementation during pregnancy
- Posted December 1, 2016
- 13
MS Symptoms May Develop Earlier in Darker, Cooler Climes
Study results suggest latitude affects timing of disease onset
- Posted November 3, 2016
- 12
Powerful MS Drug Used Early May Reverse Some Disability
But significant side effects remain an issue for Lemtrada, researcher says
- Posted October 14, 2016
- 14
Exercise May Not Lower Women’s Risk of Multiple Sclerosis
Study shows no benefit, but staying active can help ease disease symptoms, experts say
- Posted September 29, 2016
- 6
Drug Shows Promise Against MS in Mouse Study
Laquinimod seemed to slow progression of the neurological disorder, but human trials needed
- Posted September 21, 2016
- 0
Drug Shows Promise Against MS in Mouse Study
Laquinimod seemed to slow progression of the neurological disorder, but human trials needed
- Posted September 21, 2016
- 16
Treating Early Symptoms of MS May Extend Time to Diagnosis
Industry-funded study also found therapy doubled time until a relapse occurred
- Posted August 11, 2016
- 11

Page 1 of 712 3 4 5 6 7

Are You Living with Psoriasis?

A growing knowledge of the skin disease called psoriasis is leading to greater treatment choices, including personalized therapies, the U.S. Food and Drug Administration reports.

Psoriasis is an immune system disorder that causes overproduction of skin cells, resulting in scaling, pain, swelling, redness and heat. The condition affects about 7.5 million Americans.

“As we better understand the disease, researchers know more about what specific factors to target in order to develop effective treatments,” FDA dermatologist Dr. Melinda McCord said in an agency news release.

There is no cure for psoriasis, so the main goals of treatments are to stop skin cell overproduction and reduce inflammation. Current therapies include medicines applied to the skin (topical), light treatment (phototherapy), or drugs taken by mouth or given by injection.

Doctors used to take a step-by-step approach, starting patients with mild to moderate psoriasis on topical therapy. If that was ineffective, doctors moved on to phototherapy or drug treatment.